SLNO – soleno therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Soleno Therapeutics Announces Oral Presentations featuring Diazoxide Choline Extended-Release (DCCR) Tablets in Prader-Willi Syndrome at ESPE 2024
Here's Why We're Not At All Concerned With Soleno Therapeutics' (NASDAQ:SLNO) Cash Burn Situation [Yahoo! Finance]
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $70.00 price target on the stock.
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results [Yahoo! Finance]
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
Form SC 13D/A SOLENO THERAPEUTICS INC Filed by: PERCEPTIVE ADVISORS LLC
Form SCHEDULE 13G/A SOLENO THERAPEUTICS INC Filed by: Nantahala Capital Management, LLC
Form SC 13D/A SOLENO THERAPEUTICS INC Filed by: PERCEPTIVE ADVISORS LLC
Form SC 13G/A SOLENO THERAPEUTICS INC Filed by: JANUS HENDERSON GROUP PLC
Form SC 13G SOLENO THERAPEUTICS INC Filed by: Avoro Capital Advisors LLC
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.